BridgeBio Pharma, Inc. Other Noncash Income (Expense)
BridgeBio Pharma, Inc. (BBIO) reported Other Noncash Income (Expense) of -$1.50 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Cash Flow › Operating Activities
us-gaap:OtherNoncashIncomeExpense · last filed 2026-08-10
- BridgeBio Pharma, Inc. other noncash income (expense) for the quarter ending 2026-06-30 was -$1.20M.
- BridgeBio Pharma, Inc. other noncash income (expense) for the quarter ending 2026-03-31 was -$306.00K, a 1557.14% decline year-over-year.
- BridgeBio Pharma, Inc. other noncash income (expense) for the quarter ending 2025-12-31 was $434.00K.
- BridgeBio Pharma, Inc. other noncash income (expense) for the quarter ending 2025-09-30 was $1.25M, a 745.95% increase year-over-year.
- BridgeBio Pharma, Inc. other noncash income (expense) for fiscal 2025 was $1.65M, a 76.58% increase from fiscal 2024.
- BridgeBio Pharma, Inc. other noncash income (expense) for fiscal 2024 was $935.00K, a 16.44% increase from fiscal 2023.
- BridgeBio Pharma, Inc. other noncash income (expense) for fiscal 2023 was $803.00K.
- BridgeBio Pharma, Inc. other noncash income (expense) for fiscal 2022 was -$2.17M.
| Period end | Other Noncash Income (Expense) 3 month | Other Noncash Income (Expense) 3 month as first filed | Other Noncash Income (Expense) 6 month | Other Noncash Income (Expense) 6 month as first filed | Other Noncash Income (Expense) 9 month | Other Noncash Income (Expense) 9 month as first filed | Other Noncash Income (Expense) 12 month | Other Noncash Income (Expense) 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$1.20M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-10 | -$1.50M 10-Q · filed 2026-08-10 | -$1.07M derived: sum of 3 quarters · filed 2026-08-10 | $184.00K derived: sum of 4 quarters · filed 2026-08-10 | ||||
| 2026-03-31 | -$306.00K 10-Q · filed 2026-05-07 | $128.00K derived: sum of 2 quarters · filed 2026-05-07 | $1.38M derived: sum of 3 quarters · filed 2026-05-07 | $1.32M derived: sum of 4 quarters · filed 2026-08-10 | ||||
| 2025-12-31 | $434.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $1.69M derived: sum of 2 quarters · filed 2026-02-24 | $1.63M derived: sum of 3 quarters · filed 2026-08-10 | $1.65M 10-K · filed 2026-02-24 | ||||
| 2025-09-30 | $1.25M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-29 | $1.20M derived: sum of 2 quarters · filed 2026-08-10 | $1.22M 10-Q · filed 2025-10-29 | $93.00K derived: sum of 4 quarters · filed 2026-08-10 | ||||
| 2025-06-30 | -$56.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-10 | -$35.00K 10-Q · filed 2026-08-10 | $5.46M 10-Q · filed 2025-08-05 | -$1.16M derived: sum of 3 quarters · filed 2026-08-10 | -$1.01M derived: sum of 4 quarters · filed 2026-08-10 | |||
| 2025-03-31 | $21.00K 10-Q · filed 2026-05-07 | $3.97M 10-Q · filed 2025-04-29 | -$1.10M derived: sum of 2 quarters · filed 2026-05-07 | -$955.00K derived: sum of 3 quarters · filed 2026-05-07 | $2.59M derived: sum of 4 quarters · filed 2026-05-07 | |||
| 2024-12-31 | -$1.12M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | -$976.00K derived: sum of 2 quarters · filed 2026-02-24 | $2.57M derived: sum of 3 quarters · filed 2026-02-24 | $935.00K 10-K · filed 2026-02-24 | $2.76M 10-K · filed 2025-02-20 | |||
| 2024-09-30 | $148.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-29 | $3.69M derived: sum of 2 quarters · filed 2025-10-29 | $2.06M 10-Q · filed 2025-10-29 | $2.53M derived: sum of 4 quarters · filed 2026-02-24 | ||||
| 2024-06-30 | $3.54M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-05 | $1.91M 10-Q · filed 2025-08-05 | $2.38M derived: sum of 3 quarters · filed 2026-02-24 | $2.39M derived: sum of 4 quarters · filed 2026-02-24 | ||||
| 2024-03-31 | -$1.63M 10-Q · filed 2025-04-29 | -$1.16M derived: sum of 2 quarters · filed 2026-02-24 | -$1.16M derived: sum of 3 quarters · filed 2026-02-24 | -$1.14M derived: sum of 4 quarters · filed 2026-02-24 | ||||
| 2023-12-31 | $471.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $475.00K derived: sum of 2 quarters · filed 2026-02-24 | $489.00K derived: sum of 3 quarters · filed 2026-02-24 | $803.00K 10-K · filed 2026-02-24 | -$181.00K 10-K · filed 2024-02-22 | |||
| 2023-09-30 | $4.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $18.00K derived: sum of 2 quarters · filed 2024-11-12 | $332.00K 10-Q · filed 2024-11-12 | $384.00K 10-Q · filed 2023-11-02 | -$1.17M derived: sum of 4 quarters · filed 2025-02-20 | |||
| 2023-06-30 | $14.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-01 | $328.00K 10-Q · filed 2024-08-01 | -$1.18M derived: sum of 3 quarters · filed 2025-02-20 | -$994.00K derived: sum of 4 quarters · filed 2025-02-20 | ||||
| 2023-03-31 | $314.00K 10-Q · filed 2024-05-02 | $203.00K 10-Q · filed 2023-05-04 | -$1.19M derived: sum of 2 quarters · filed 2025-02-20 | -$1.01M derived: sum of 3 quarters · filed 2025-02-20 | -$1.26M derived: sum of 4 quarters · filed 2025-02-20 | |||
| 2022-12-31 | -$1.50M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-20 | -$1.32M derived: sum of 2 quarters · filed 2025-02-20 | -$1.57M derived: sum of 3 quarters · filed 2025-02-20 | -$2.17M 10-K · filed 2025-02-20 | -$604.00K 10-K · filed 2023-02-23 | |||
| 2022-09-30 | $183.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02 | -$66.00K derived: sum of 2 quarters · filed 2023-11-02 | -$670.00K 10-Q · filed 2023-11-02 | -$4.69M 10-Q · filed 2022-11-03 | -$440.00K derived: sum of 4 quarters · filed 2024-02-22 | |||
| 2022-06-30 | -$249.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | -$853.00K 10-Q · filed 2023-08-03 | -$3.74M 10-Q · filed 2022-08-04 | -$623.00K derived: sum of 3 quarters · filed 2024-02-22 | -$4.04M derived: sum of 4 quarters · filed 2024-02-22 | |||
| 2022-03-31 | -$604.00K 10-Q · filed 2023-05-04 | -$374.00K derived: sum of 2 quarters · filed 2024-02-22 | -$3.79M derived: sum of 3 quarters · filed 2024-02-22 | -$6.47M derived: sum of 4 quarters · filed 2024-02-22 | ||||
| 2021-12-31 | $230.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-22 | -$3.19M derived: sum of 2 quarters · filed 2024-02-22 | -$5.86M derived: sum of 3 quarters · filed 2024-02-22 | -$7.09M 10-K · filed 2024-02-22 | ||||
| 2021-09-30 | -$3.42M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | -$6.09M derived: sum of 2 quarters · filed 2022-11-03 | -$7.32M 10-Q · filed 2022-11-03 | -$8.51M 10-Q · filed 2021-11-04 | -$4.41M derived: sum of 4 quarters · filed 2023-02-23 | |||
| 2021-06-30 | -$2.68M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | -$3.91M 10-Q · filed 2022-08-04 | -$7.21M 10-Q · filed 2021-08-05 | -$997.00K derived: sum of 3 quarters · filed 2023-02-23 | -$4.69M derived: sum of 4 quarters · filed 2023-02-23 | |||
| 2021-03-31 | -$1.23M 10-Q · filed 2022-05-05 | -$5.10M 10-Q · filed 2021-05-06 | $1.68M derived: sum of 2 quarters · filed 2023-02-23 | -$2.01M derived: sum of 3 quarters · filed 2023-02-23 | -$1.96M derived: sum of 4 quarters · filed 2023-02-23 | |||
| 2020-12-31 | $2.91M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-23 | -$781.00K derived: sum of 2 quarters · filed 2023-02-23 | -$732.00K derived: sum of 3 quarters · filed 2023-02-23 | -$1.23M 10-K · filed 2023-02-23 | -$2.68M 10-K · filed 2021-02-25 | |||
| 2020-09-30 | -$3.69M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | -$3.64M derived: sum of 2 quarters · filed 2021-11-04 | -$4.13M 10-Q · filed 2021-11-04 | -$7.32M 10-Q · filed 2020-11-05 | $661.00K derived: sum of 4 quarters · filed 2022-02-25 | |||
| 2020-06-30 | $49.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | -$444.00K 10-Q · filed 2021-08-05 | -$2.48M 10-Q · filed 2020-08-11 | $4.35M derived: sum of 3 quarters · filed 2022-02-25 | $3.58M derived: sum of 4 quarters · filed 2022-02-25 | |||
| 2020-03-31 | -$493.00K 10-Q · filed 2021-05-06 | -$1.03M 10-Q · filed 2020-05-14 | $4.30M derived: sum of 2 quarters · filed 2022-02-25 | $3.53M derived: sum of 3 quarters · filed 2022-02-25 | $3.39M derived: sum of 4 quarters · filed 2022-02-25 | |||
| 2019-12-31 | $4.79M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-25 | $4.02M derived: sum of 2 quarters · filed 2022-02-25 | $3.89M derived: sum of 3 quarters · filed 2022-02-25 | $3.55M 10-K · filed 2022-02-25 | -$1.35M 10-K · filed 2020-03-03 | |||
| 2019-09-30 | -$776.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | -$909.00K derived: sum of 2 quarters · filed 2020-11-05 | -$1.25M 10-Q · filed 2020-11-05 | |||||
| 2019-06-30 | -$133.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-11 | -$472.00K 10-Q · filed 2020-08-11 | ||||||
| 2019-03-31 | -$339.00K 10-Q · filed 2020-05-14 | |||||||
| 2018-12-31 | -$252.00K 10-K · filed 2021-02-25 | -$442.00K 10-K · filed 2020-03-03 | ||||||
| 2017-12-31 | -$260.00K 10-K · filed 2020-03-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |